Daniel G Bausch

Summary

Affiliation: Tulane University
Country: USA

Publications

  1. doi request reprint New opportunities for field research on the pathogenesis and treatment of Lassa fever
    Sheik Humarr Khan
    Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone
    Antiviral Res 78:103-15. 2008
  2. doi request reprint Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions
    Daniel G Bausch
    Tulane University Health Sciences Center, New Orleans, LA, United States
    Antiviral Res 78:150-61. 2008
  3. pmc Hantavirus pulmonary syndrome in Santa Cruz, Bolivia: outbreak investigation and antibody prevalence study
    Joel M Montgomery
    Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
    PLoS Negl Trop Dis 6:e1840. 2012
  4. pmc Ribavirin for lassa Fever postexposure prophylaxis
    Christiane M Hadi
    Tulane University Health Sciences Center, New Orleans, Louisiana, USA C M Hadi, D G Bausch Ministry of Health and Sanitation, Kenema, Sierra Leone A Goba, S H Khan, J Bangura, M Sankoh, S Koroma, B Juana International Center for Research on Tropical Infections, N Zerekore, Guinea A Bah, M Coulibaly and Tulane School of Public Health and Tropical Medicine, New Orleans D G Bausch
    Emerg Infect Dis 16:2009-11. 2010
  5. pmc On the front lines of Lassa fever
    Daniel G Bausch
    Emerg Infect Dis 10:1889-90. 2004
  6. pmc Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance
    Luis M Branco
    BioFactura, Inc, Rockville, Maryland, USA
    Virol J 5:74. 2008
  7. doi request reprint Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever
    Daniel G Bausch
    Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Clin Infect Dis 51:1435-41. 2010
  8. ncbi request reprint Assessment of the risk of Ebola virus transmission from bodily fluids and fomites
    Daniel G Bausch
    Tulane School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA
    J Infect Dis 196:S142-7. 2007
  9. ncbi request reprint Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient
    Daniel G Bausch
    Tulane School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA
    J Infect Dis 196:S136-41. 2007
  10. ncbi request reprint Development of vaccines for Marburg hemorrhagic fever
    Daniel G Bausch
    Department of Tropical Medicine, SL 17, Tulane School of Public Health and Tropical Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA
    Expert Rev Vaccines 6:57-74. 2007

Collaborators

Detail Information

Publications28

  1. doi request reprint New opportunities for field research on the pathogenesis and treatment of Lassa fever
    Sheik Humarr Khan
    Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone
    Antiviral Res 78:103-15. 2008
    ..Here, we review the present literature on treatment and pathogenesis of LF and outline priorities for future research in the field made possible by the improved research capacity of the MRU LFN...
  2. doi request reprint Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions
    Daniel G Bausch
    Tulane University Health Sciences Center, New Orleans, LA, United States
    Antiviral Res 78:150-61. 2008
    ..Here, we review the present research priorities and environment for field study of the filovirus hemorrhagic fevers and outline a strategy for future prospective clinical research on treatment and vaccine prevention...
  3. pmc Hantavirus pulmonary syndrome in Santa Cruz, Bolivia: outbreak investigation and antibody prevalence study
    Joel M Montgomery
    Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
    PLoS Negl Trop Dis 6:e1840. 2012
    ..Hantavirus infection appears to be common in the Santa Cruz Department, but more comprehensive surveillance and field studies are needed to fully understand the epidemiology and risk to humans...
  4. pmc Ribavirin for lassa Fever postexposure prophylaxis
    Christiane M Hadi
    Tulane University Health Sciences Center, New Orleans, Louisiana, USA C M Hadi, D G Bausch Ministry of Health and Sanitation, Kenema, Sierra Leone A Goba, S H Khan, J Bangura, M Sankoh, S Koroma, B Juana International Center for Research on Tropical Infections, N Zerekore, Guinea A Bah, M Coulibaly and Tulane School of Public Health and Tropical Medicine, New Orleans D G Bausch
    Emerg Infect Dis 16:2009-11. 2010
    ....
  5. pmc On the front lines of Lassa fever
    Daniel G Bausch
    Emerg Infect Dis 10:1889-90. 2004
  6. pmc Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance
    Luis M Branco
    BioFactura, Inc, Rockville, Maryland, USA
    Virol J 5:74. 2008
    ..Bacterial-based systems were engineered for expression and purification of recombinant LASV nucleoprotein (NP), glycoprotein 1 (GP1), and glycoprotein 2 (GP2)...
  7. doi request reprint Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever
    Daniel G Bausch
    Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Clin Infect Dis 51:1435-41. 2010
    ..We recommend oral ribavirin postexposure prophylaxis for Lassa fever exclusively for definitive high-risk exposures. These guidelines may also serve for exposure to other hemorrhagic fever viruses susceptible to ribavirin...
  8. ncbi request reprint Assessment of the risk of Ebola virus transmission from bodily fluids and fomites
    Daniel G Bausch
    Tulane School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA
    J Infect Dis 196:S142-7. 2007
    ....
  9. ncbi request reprint Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient
    Daniel G Bausch
    Tulane School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA
    J Infect Dis 196:S136-41. 2007
    ..A summary of the opportunities for and challenges to improving treatment of filovirus hemorrhagic fevers is presented here...
  10. ncbi request reprint Development of vaccines for Marburg hemorrhagic fever
    Daniel G Bausch
    Department of Tropical Medicine, SL 17, Tulane School of Public Health and Tropical Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA
    Expert Rev Vaccines 6:57-74. 2007
    ..In particular, a vaccine based on attenuated recombinant vesicular stomatitis virus was recently shown to have both preventive and postexposure efficacy...
  11. pmc Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo
    Daniel G Bausch
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 9:1531-7. 2003
    ..Secondary transmission appears to be less common with Marburg virus than with Ebola virus, the other known filovirus...
  12. ncbi request reprint Hantavirus pulmonary syndrome in Central Bolivia: relationships between reservoir hosts, habitats, and viral genotypes
    Darin S Carroll
    Division of Viral and Rickettsial Diseases, Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Am J Trop Med Hyg 72:42-6. 2005
    ..callosus was 99% identical to viral sequences obtained from the HPS patient in this area, implicating C. callosus as the host and Laguna Negra virus as the agent responsible for the HPS case near Concepcion...
  13. pmc Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome
    Jonathan S Towner
    Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 78:4330-41. 2004
    ..Furthermore, both sequence and epidemiologic data are consistent with the outbreak having originated from a single introduction into the human population...
  14. ncbi request reprint Marburg hemorrhagic fever associated with multiple genetic lineages of virus
    Daniel G Bausch
    Centers for Disease Control and Prevention, Atlanta, USA
    N Engl J Med 355:909-19. 2006
    ..An outbreak of Marburg hemorrhagic fever was first observed in a gold-mining village in northeastern Democratic Republic of the Congo in October 1998...
  15. ncbi request reprint Lassa virus-infected rodents in refugee camps in Guinea: a looming threat to public health in a politically unstable region
    Joseph Fair
    Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA
    Vector Borne Zoonotic Dis 7:167-71. 2007
    ..The methodology used represents a potential model for rapid public health assessments in the setting of complex humanitarian emergencies...
  16. pmc Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects
    Luis M Branco
    Tulane University Health Sciences Center, New Orleans, LA, USA
    Virol J 7:306. 2010
    ....
  17. ncbi request reprint Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus
    Pierre E Rollin
    Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 196:S364-71. 2007
    ..This study has identified levels of analytes with prognostic value, which can also be used to target therapeutic interventions, and expands on the findings of prior blood tests conducted on this group of patients...
  18. pmc A historical look at the first reported cases of Lassa fever: IgG antibodies 40 years after acute infection
    Nell Bond
    Tulane School of Public Health and Tropical Medicine, Department of Tropical Medicine, New Orleans, LA, USA
    Am J Trop Med Hyg 88:241-4. 2013
    ..One person was likely infected in 1952, 17 years before the first recognized outbreak. We briefly recount the fascinating stories of these three pioneers and their important contribution to our understanding of Lassa fever...
  19. ncbi request reprint Old World hantaviruses in rodents in New Orleans, Louisiana
    Robert W Cross
    Tulane University Health Sciences Center, New Orleans, Louisiana New Orleans Termite, Mosquito, and Rodent Control Board, New Orleans, Louisiana Rocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, Hamilton, Montana
    Am J Trop Med Hyg 90:897-901. 2014
    ....
  20. pmc Housing equity for health equity: a rights-based approach to the control of Lassa fever in post-war Sierra Leone
    J Daniel Kelly
    Department of Tropical Medicine, Tulane School of Public Health and Tropical Medicine, 1430 Tulane Avenue SL 17, New Orleans, LA, 70112, USA
    BMC Int Health Hum Rights 13:2. 2013
    ..The manuscript is designed to spur discussion and action towards provision of housing and prevention of disease in one of the world's most vulnerable populations...
  21. pmc Factors associated with nosocomial SARS-CoV transmission among healthcare workers in Hanoi, Vietnam, 2003
    Mary G Reynolds
    National Centers for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    BMC Public Health 6:207. 2006
    ....
  22. pmc Acute arboviral infections in Guinea, West Africa, 2006
    Emily S Jentes
    Department of Tropical Medicine, Tulane School of Public Health and Tropical Medicine, New Orleans, LA, USA
    Am J Trop Med Hyg 83:388-94. 2010
    ..Improving surveillance and laboratory capacity for arbovirus diagnoses will be integral to understanding the burden posed by these agents in the region...
  23. doi request reprint Lassa fever in post-conflict sierra leone
    Jeffrey G Shaffer
    Department of Biostatistics and Bioinformatics, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America
    PLoS Negl Trop Dis 8:e2748. 2014
    ..When the violent civil conflict in Sierra Leone (1991 to 2002) ended, an international consortium assisted in restoration of the LF program at Kenema Government Hospital (KGH) in an area with the world's highest incidence of the disease...
  24. pmc Syndromic diagnosis of malaria in rural Sierra Leone and proposed additions to the national integrated management of childhood illness guidelines for fever
    Obinna N Nnedu
    Tulane University Health Sciences Center, New Orleans, Louisiana, USA
    Am J Trop Med Hyg 82:525-8. 2010
    ..Incorporating bed net use and splenomegaly into the national Integrated Management of Childhood Illness guidelines for evaluation of fever may further enhance diagnostic accuracy for malaria...
  25. ncbi request reprint A DNA vaccine for the prevention of Ebola virus infection
    MarkAlain Dery
    Tulane University Health Sciences Center, Department of Medicine, Infectious Diseases Section, 1430 Tulane Ave SL 87, New Orleans, LA 70112 2699, USA
    Curr Opin Mol Ther 10:285-93. 2008
    ..A phase I clinical trial demonstrated a good safety profile, with most adverse events limited to the site of injection and largely attributable to the delivery...
  26. ncbi request reprint Viral hemorrhagic fevers including hantavirus pulmonary syndrome in the Americas
    Daniel G Bausch
    Special Pathogens Branch, MS G 14, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    Clin Lab Med 22:981-1020, viii. 2002
    ..Clinical management is largely supportive, with a special emphasis on safe nursing practices to prevent nosocomial transmission...
  27. pmc Studies of reservoir hosts for Marburg virus
    Robert Swanepoel
    National Institute for Communicable Diseases, Sandringham, Republic of South Africa
    Emerg Infect Dis 13:1847-51. 2007
    ..6% of 2 species of insectivorous bat and 1 species of fruit bat. We found antibody to the virus in the serum of 9.7% of 1 of the insectivorous species and in 20.5% of the fruit bat species, but attempts to isolate virus were unsuccessful...
  28. ncbi request reprint Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment
    Robert Colebunders
    Institute of Tropical Medicine Antwerp, Antwerp, B 2000, Belgium
    J Infect Dis 196:S148-53. 2007
    ..Treatment in isolation wards was acceptable, but the quality of clinical documentation was unsatisfactory. Improved clinical documentation is necessary for a basic evaluation of supportive treatment...